
Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
Fierce editors discuss Shire's increasingly complicated ambition to acquire Baxalta, the changing climate of biotech venture capital and the future of Valeant Pharmaceuticals.
Shire's byzantine Baxalta pursuit, biotech's pragmatic winter and Valeant's CEO shakeup is an episode from FierceBiotech Radio. Fierce editors discuss Shire's increasingly complicated ambition to acquire Baxalta, the changing climate of bio...
This episode belongs to FierceBiotech Radio.
Use the player on this page to stream the episode online.
Published Jan 8, 2016, 22:37 long, audio available.